FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4292136516> ?p ?o ?g. }

• W4292136516 endingPage "152083" @default.
• W4292136516 startingPage "152083" @default.
• W4292136516 abstract "To evaluate the risk of incident dementia associated with the use of biologics or targeted synthetic DMARDs (b/tsDMARD) compared to conventional synthetic (cs) DMARDS only in patients with rheumatoid arthritis (RA).We analyzed claims data from the Center for Medicare & Medicare Services (CMS) from 2006-2017. Patients with RA were identified as adults ≥40 years old and two RA diagnoses by a rheumatologist > 7 and < 365 days apart. Patients with a prior diagnosis of dementia were excluded. Use of cs/b/tsDMARDs was the exposure of interest. Person-time was classified as either: 1) b/tsDMARD exposed, which included tumor necrosis factor alpha inhibitors (TNFi)-bDMARDs, non-TNFi-bDMARDs or tsDMARDs with or without csDMARDs; 2) csDMARD-exposed: any csDMARD without b/tsDMARD. Patients could contribute time to different exposure groups if they changed medications. Incident dementia was defined as: 1 inpatient OR 2 outpatients ICD-9-CM or ICD-10 claims for dementia, OR prescription of a dementia-specific medication (rivastigmine, galantamine, memantine, donepezil, tacrine). Age-adjusted incident rates (IR) were calculated, and univariate and multivariate Cox proportional hazard models were used to calculate Hazard Ratios (HR) and 95% confidence intervals (CI).We identified 141,326 eligible RA patients; 80% female and 75.3% white, median age 67 years and mean (SD) exposure time of 1.1 (1.5) years. There were 233,271 initiations of c/b/tsDMARDS and 3,794 cases of incident dementia during follow up. The crude IR of dementia was 2.0 (95% CI 1.9-2.1) per 100 person-years for patients on csDMARDs and 1.3 (95% CI 1.2-1.4) for patients on any b/tsDMARD. Patients on b/tsDMARDs had an adjusted 19% lower risk for dementia than patients on csDMARDs [HR 0.81 (95% CI 0.76-0.87)]. Subgroup analysis found comparable risk reductions between TNFi, non-TNFi, and tsDMARDs. on the risk of dementia.The incidence of dementia in patients with RA was lower in patients receiving b/tsDMARDs when compared to patients on csDMARD only. No differences were observed between different classes of b/tsDMARDs, suggesting that decreased risk is possibly explained by the overall decrease in inflammation rather than a specific mechanism of action of these drugs." @default.
• W4292136516 created "2022-08-17" @default.
• W4292136516 creator A5043053903 @default.
• W4292136516 creator A5057080481 @default.
• W4292136516 creator A5065910861 @default.
• W4292136516 creator A5071496904 @default.
• W4292136516 creator A5071538028 @default.
• W4292136516 creator A5075536702 @default.
• W4292136516 date "2022-12-01" @default.
• W4292136516 modified "2023-10-14" @default.
• W4292136516 title "Incidence of dementia in patients with rheumatoid arthritis and association with disease modifying anti-rheumatic drugs – Analysis of a national claims database" @default.
• W4292136516 cites W1653750413 @default.
• W4292136516 cites W1934443959 @default.
• W4292136516 cites W1964098393 @default.
• W4292136516 cites W1983522119 @default.
• W4292136516 cites W2011556223 @default.
• W4292136516 cites W2037882607 @default.
• W4292136516 cites W2038981426 @default.
• W4292136516 cites W2042690206 @default.
• W4292136516 cites W2050034771 @default.
• W4292136516 cites W2061326496 @default.
• W4292136516 cites W2073458184 @default.
• W4292136516 cites W2124681501 @default.
• W4292136516 cites W2128349279 @default.
• W4292136516 cites W2128509298 @default.
• W4292136516 cites W2135032335 @default.
• W4292136516 cites W2150294937 @default.
• W4292136516 cites W2154746519 @default.
• W4292136516 cites W2169097752 @default.
• W4292136516 cites W2275737843 @default.
• W4292136516 cites W2489613804 @default.
• W4292136516 cites W2562247461 @default.
• W4292136516 cites W2740614417 @default.
• W4292136516 cites W2744015013 @default.
• W4292136516 cites W2754817113 @default.
• W4292136516 cites W2759782656 @default.
• W4292136516 cites W2767395458 @default.
• W4292136516 cites W2804793107 @default.
• W4292136516 cites W2864652551 @default.
• W4292136516 cites W2888418802 @default.
• W4292136516 cites W2890285918 @default.
• W4292136516 cites W2891379852 @default.
• W4292136516 cites W2921889468 @default.
• W4292136516 cites W2925611952 @default.
• W4292136516 cites W2939208482 @default.
• W4292136516 cites W2960505072 @default.
• W4292136516 cites W3011926553 @default.
• W4292136516 cites W3012855465 @default.
• W4292136516 cites W3012952533 @default.
• W4292136516 cites W3032601476 @default.
• W4292136516 cites W3089504340 @default.
• W4292136516 cites W3120424873 @default.
• W4292136516 cites W3123347830 @default.
• W4292136516 cites W3127744380 @default.
• W4292136516 cites W3131778757 @default.
• W4292136516 cites W4223601481 @default.
• W4292136516 doi "https://doi.org/10.1016/j.semarthrit.2022.152083" @default.
• W4292136516 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36155968" @default.
• W4292136516 hasPublicationYear "2022" @default.
• W4292136516 type Work @default.
• W4292136516 citedByCount "3" @default.
• W4292136516 countsByYear W42921365162022 @default.
• W4292136516 countsByYear W42921365162023 @default.
• W4292136516 crossrefType "journal-article" @default.
• W4292136516 hasAuthorship W4292136516A5043053903 @default.
• W4292136516 hasAuthorship W4292136516A5057080481 @default.
• W4292136516 hasAuthorship W4292136516A5065910861 @default.
• W4292136516 hasAuthorship W4292136516A5071496904 @default.
• W4292136516 hasAuthorship W4292136516A5071538028 @default.
• W4292136516 hasAuthorship W4292136516A5075536702 @default.
• W4292136516 hasConcept C120665830 @default.
• W4292136516 hasConcept C121332964 @default.
• W4292136516 hasConcept C126322002 @default.
• W4292136516 hasConcept C16005928 @default.
• W4292136516 hasConcept C207103383 @default.
• W4292136516 hasConcept C2776260265 @default.
• W4292136516 hasConcept C2776332859 @default.
• W4292136516 hasConcept C2776467144 @default.
• W4292136516 hasConcept C2777575956 @default.
• W4292136516 hasConcept C2779056891 @default.
• W4292136516 hasConcept C2779134260 @default.
• W4292136516 hasConcept C2779483572 @default.
• W4292136516 hasConcept C2780564577 @default.
• W4292136516 hasConcept C2780904820 @default.
• W4292136516 hasConcept C44249647 @default.
• W4292136516 hasConcept C50382708 @default.
• W4292136516 hasConcept C61511704 @default.
• W4292136516 hasConcept C71924100 @default.
• W4292136516 hasConceptScore W4292136516C120665830 @default.
• W4292136516 hasConceptScore W4292136516C121332964 @default.
• W4292136516 hasConceptScore W4292136516C126322002 @default.
• W4292136516 hasConceptScore W4292136516C16005928 @default.
• W4292136516 hasConceptScore W4292136516C207103383 @default.
• W4292136516 hasConceptScore W4292136516C2776260265 @default.
• W4292136516 hasConceptScore W4292136516C2776332859 @default.
• W4292136516 hasConceptScore W4292136516C2776467144 @default.
• W4292136516 hasConceptScore W4292136516C2777575956 @default.
• W4292136516 hasConceptScore W4292136516C2779056891 @default.

• next